ImmunityBio (IBRX) EBITDA (2014 - 2026)
ImmunityBio (IBRX) reported EBITDA of -$57.29 million for Q2 2026, compared with -$67.41 million a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ImmunityBio's EBITDA came in at -$235.2 million; for FY2025, it came in at -$240.5 million.
- By year, EBITDA came in at -$326.63 million in FY2024, -$343.74 million in FY2023, -$333.04 million in FY2022 and -$316.04 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$106.9 million in Q1 2023 and a high of -$51.68 million in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$65.41 million (Q1 2026), -$60.82 million (Q4 2025) and -$51.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | -57.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.29 Mn |
| Mar 31, 2026 | -65.41 Mn |
| Dec 31, 2025 | -60.82 Mn |
| Sep 30, 2025 | -51.68 Mn |
| Jun 30, 2025 | -67.41 Mn |
| Mar 31, 2025 | -60.60 Mn |
| Dec 31, 2024 | -65.26 Mn |
| Sep 30, 2024 | -75.80 Mn |
| Jun 30, 2024 | -94.93 Mn |
| Mar 31, 2024 | -90.64 Mn |
| Dec 31, 2023 | -80.83 Mn |
| Sep 30, 2023 | -75.55 Mn |
| Jun 30, 2023 | -80.46 Mn |
| Mar 31, 2023 | -106.90 Mn |
| Dec 31, 2022 | -79.67 Mn |
| Sep 30, 2022 | -86.30 Mn |
| Jun 30, 2022 | -75.18 Mn |
| Mar 31, 2022 | -91.88 Mn |
| Dec 31, 2021 | -75.68 Mn |
| Sep 30, 2021 | -75.15 Mn |
API Access
ImmunityBio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();